Table 3.
Overall preterm birth | ||||||
8-OHdG | 8-Isoprostane | |||||
N (cases, controls) | OR (95% CI) | p value | N (cases, controls) | OR (95% CI) | p value | |
Visit 1 | 123, 326 | 0.25 (0.14, 0.46) | <0.01 | 123, 326 | 1.72 (1.18, 2.51) | 0.01 |
Visit 2 | 114, 289 | 0.21 (0.10, 0.42) | <0.01 | 114, 289 | 2.33 (1.44, 3.77) | <0.01 |
Visit 3 | 107, 282 | 0.44 (0.24, 0.81) | <0.01 | 107, 282 | 2.05 (1.31, 3.19) | <0.01 |
Visit 4 | 59, 294 | 0.45 (0.23, 0.90) | 0.02 | 59, 294 | 1.76 (1.08, 2.88) | 0.02 |
Spontaneous preterm birth | ||||||
8-OHdG | 8-Isoprostane | |||||
N (cases, controls) | OR (95% CI) | p value | N (cases, controls) | OR (95% CI) | p value | |
Visit 1 | 54, 326 | 0.26 (0.12, 0.56) | <0.01 | 54, 326 | 2.72 (1.46, 5.06) | <0.01 |
Visit 2 | 52, 289 | 0.30 (0.13, 0.71) | <0.01 | 52, 289 | 7.10 (2.80, 18.0) | <0.01 |
Visit 3 | 47, 282 | 0.33 (0.14, 0.74) | <0.01 | 47, 282 | 4.45 (1.96, 10.1) | <0.01 |
Visit 4 | 24, 294 | 0.75 (0.28, 2.01) | 0.57 | 24, 294 | 5.27 (1.82, 15.3) | <0.01 |
Placental preterm birth | ||||||
8-OHdG | 8-Isoprostane | |||||
N (cases, controls) | OR (95% CI) | p value | N (cases, controls) | OR (95% CI) | p value | |
Visit 1 | 33, 326 | 0.21 (0.07, 0.58) | <0.01 | 33, 326 | 1.02 (0.62, 1.69) | 0.93 |
Visit 2 | 29, 289 | 0.12 (0.04, 0.40) | <0.01 | 29, 289 | 1.19 (0.60, 2.34) | 0.62 |
Visit 3 | 30, 282 | 0.40 (0.17, 0.94) | 0.04 | 30, 282 | 0.79 (0.44, 1.43) | 0.44 |
Visit 4 | 12, 294 | 0.19 (0.04, 0.85) | 0.03 | 12, 294 | 0.59 (0.29, 1.19) | 0.14 |
Abbreviations: 8-OHdG, 8-hydroxydeoxyguanosine; OR, odds ratio. Models adjusted for urinary specific gravity, maternal age, race/ethnicity, education level, health insurance provider, and pre-pregnancy body mass index (BMI).